Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. The company is headquartered in Waltham, Massachusetts and currently employs 11,000 full-time employees. The firm has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Dr. Prahlad Singh 2016 'den beri şirketle birlikte olan Revvity Inc 'in President 'ıdır.
RVTY hissesinin fiyat performansı nasıl?
RVTY 'in mevcut fiyatı $85.01 'dir, son işlem günde 2.46% azalmış etti.
Revvity Inc için ana iş temaları veya sektörler nelerdir?
Revvity Inc Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
Revvity Inc 'in piyasa değerlemesi nedir?
Revvity Inc 'in mevcut piyasa değerlemesi $9.5B 'dir
Revvity Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 20 analist Revvity Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 7 güçlü al, 10 al, 8 tut, 1 sat ve 7 güçlü sat içermektedir